Pioglitazone: all 341 studies that test it
Page 4 of 4. Open to participants first (28), then studies with results posted, then the rest; newest registration first within each.
- Pioglitazone on Cardiac Function and Large Arteries (PICCOLA Study)CompletedNCT00485056Phase 4
- Comparison Between Pioglitazone and SES With type2 DMCompletedNCT00482183Phase 2/3
- Effects of Pioglitazone in Type 2 Diabetes Mellitus and Coronary Heart DiseaseCompletedNCT00479986Phase 4
- The Effects of TZD on Fat Metabolism and Insulin Sensitivity in GH-Replaced GHD PatientsCompletedNCT00459940Not applicable
- Medication in Early Diabetes (MED) StudyWithdrawnNCT00437970Phase 4
- Retreatment of Chronic Hepatitis C Non-responders With Pegylated Interferon Alpha Plus Ribavirin Plus PioglitazoneCompletedNCT00433069Phase 2
- Effects of Pioglitazone Treatment on Sympathetic Nervous System Function in Metabolic Syndrome ObesityStatus unknownNCT00408850Phase 3
- "TAKE TIME" Pioglitazone Reverses Defects in Mitochondrial Biogenesis in Patients With T2DMCompletedNCT00402012Phase 4
- Efficacy and Safety of Acitretin Plus Pioglitazone in Patients With PsoriasisCompletedNCT00395941Phase 2
- "Pecos" B-adrenergic and PPAR-G Stimulation Upregulates Lipid Metabolism in Human Subcutaneous FatCompletedNCT00377975Phase 2
- PIoglitazone for PrEvention of Restenosis in Diabetic PatientsStatus unknownNCT00376870Phase 3
- Efficacy, Safety and Tolerability of Pioglitazone-Azilsartan in Subjects With Type 2 Diabetes MellitusTerminatedNCT00376181Phase 3
- Metabolic Effects of Thiazolidinediones in Chronic Kidney DiseaseTerminatedNCT00368017Phase 2
- Pioglitazone and Losartan Provides Additional RenoprotectionCompletedNCT00364988Not applicable
- Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic AdultsCompletedNCT00352287Phase 4
- Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and DyslipidemiaCompletedNCT00331487Phase 3
- Effect of Pioglitazone on Ambulatory Blood PressureCompletedNCT00328393Phase 3
- The Effect of Pioglitazone and Rosiglitazone on Atherosclerotic and Inflammatory Markers in Patients With Metabolic SyndromeCompletedNCT00314561Phase 4
- Effects of Fats on Blood Glucose in People With and Without Type 2 Diabetes MellitusCompletedNCT00308373Not applicable
- Pioglitazone in Impaired Glucose ToleranceWithdrawnNCT00306826Phase 4
- Role of Pioglitazone in Preventing DiabetesCompletedNCT00276497Phase 1
- Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or InsulinCompletedNCT00269061Phase 1
- Pilot Test of ACTOS in Multiple Sclerosis: Safety and TolerabilityCompletedNCT00242177Phase 1
- Effect of Pioglitazone on Left Ventricular Diastolic Function in Type 2 Diabetes MellitusWithdrawnNCT00232362Phase 1
- Role of Pioglitazone in the Treatment of Non-alcoholic Steatohepatitis (NASH)CompletedNCT00227110Phase 4
- GALLEX 6: Study to Evaluate the Safety and Tolerability of Tesaglitazar in Patients With Type 2 Diabetes MellitusTerminatedNCT00226330Phase 3
- Efficacy Study of Pioglitazone and Glimepiride on the Rate of Progression of Atherosclerotic Disease.CompletedNCT00225264Phase 3
- Pioglitazone Protects Diabetes Mellitus (DM) Patients Against Re-Infarction (PPAR Study)TerminatedNCT00212004Phase 4
- Pioglitazone in Hepatitis CCompletedNCT00189163Phase 4
- Efficacy of Pioglitazone on Macrovascular Outcome in Patients With Type 2 DiabetesCompletedNCT00174993Phase 3
- Abdominal Adipose Tissue Distribution in Type 2 Diabetic Patients Treated During 6 Months With Pioglitazone or InsulinTerminatedNCT00159211Not applicable
- Treatment of Coronary Atherosclerosis by Insulin Sensitizers in Insulin-Resistant PatientsStatus unknownNCT00155350Phase 4
- Effects of Pioglitazone in Congenital Adrenal HyperplasiaCompletedNCT00151710Not applicable
- Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 PatientsTerminatedNCT00148850Phase 3
- Pioglitazone Treatment in Polycystic Ovary SyndromeCompletedNCT00145340Phase 4
- Placebo and Active Controlled Study of Rivoglitazone in Type 2 DiabetesCompletedNCT00143520Phase 2/3
- Extension to a Study on the Efficacy and Safety of Vildagliptin in Combination With Pioglitazone in Patients With Type 2 DiabetesCompletedNCT00138554Phase 3
- Effects of Insulin Sensitizers in Subjects With Impaired Glucose ToleranceCompletedNCT00108615Phase 4
- Study of Muraglitazar Versus Pioglitazone in Type 2 DiabetesCompletedNCT00106808Phase 3
- Comparison of Biphasic Insulin Aspart 70/30 With Anti-Diabetic Drugs in Subjects With Type 2 DiabetesCompletedNCT00097279Phase 3
- Treatment of Nonalcoholic Steatohepatitis With PioglitazoneCompletedNCT00013598Phase 2